DarioHealth Corp. announced on September 2, 2025, the launch of five new contracts with self-insured employers, all of which went live during the second and third quarters of 2025. These programs feature Dario's full cardiometabolic suite, reinforcing demand for integrated, multi-condition solutions. Notably, one of these contracts is with the company's largest employer to date, significantly expanding its market presence.
These new customer launches collectively represent 107,000 lives covered, demonstrating substantial growth in Dario's Business-to-Business-to-Consumer (B2B2C) momentum and recurring revenue. Steven Nelson, President and Chief Commercial Officer, stated that employer contracts continue to be a powerful driver of near-term growth. He also noted that 80% of the new accounts signed in 2025 are for multi-condition programs.
The company's pipeline of commercial opportunities has increased to $67 million. Dario remains confident in its ability to reach approximately 40 new client signings by year-end 2025, representing a 35% increase over 2024. The cardiometabolic suite has demonstrated a 23% reduction in hospitalizations, a 9% reduction in healthcare utilization, and a $5,000 reduction in employer costs per user.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.